Live Pfizer updates

Live Pfizer news coverage of developments with the latest updates. Stay on top of latest Pfizer news stories and find out what just happened, what is going on with Pfizer. The latest real-time news updates and headlines on Pfizer
Pfizer’s Covid Oral Anti-Viral on Australian Benefits Scheme
COVID-19 Polarizes Trust in Science Amid Pandemic
Drug Candidate Found to Neutralize Covid, Reduce Infection Length
New Drug Candidate Neutralizes Coronavirus, Shortens Infection
TGA Product Information safety updates 27 March
Acquisitions End Existing Partnerships
Emory innovators step into spotlight
Paxlovid Reduces Covid Risk of Death, Health Issues
Covid vaccine safety report – 23-03-2023
UW Study: Vaccine Shopping Effects on Pandemic Rollout
XTANDI Plus Leuprolide Enhances MFS in Non-Metastatic Prostate Cancer
FDA Backs Pfizer’s PAXLOVID After Advisory Committee Vote
Lower Risk of Hospital Admission Linked to Paxlovid
US and Niger: Strategic Alliance Established
KAIST Pioneers AI Analysis of Drug-Drug Interactions Involving Paxlovid
U.S. Approves Pfizer/BioNTech Covid Booster for Kids Under 5
Racial Disparities in Prostate Cancer Linked to Hospital Care
Pfizer Pledges $43B to Fight Cancer
FDA approves Pfizer’s Zavgepant migraine nasal spray
Versatile Covid vaccine in works
Community Engagement Can Boost Clinical Trial Diversity: Study
Covid vaccine safety report – 09-03-2023
Kidney Lesions Linked to Heart Disease in Chronic Kidney Disease
Health Secretary announces Spring Booster and Evergreen offer
Residual Inflammation Strongly Predicts Cardiovascular Events, Death After Statin Therapy
Stronger Side Effects, Longer Lasting Vax
US Gov’t Invested Decades in mRNA Covid Vaccine Dev
US Govt Invested Decades in mRNA Covid-19 Vaccine Dev
TGA Product Information safety updates 2 March
Australian Cell and Gene Catalyst takes step forward
Pfizer/BioNTech Seek US Emergency OK for COVID Booster in Kids Under 5
Pfizer Vaccine Candidate Gains FDA Support for RSV in Older Adults
ATAGI recommendations on use of Moderna bivalent Covid vaccine
60 Years Later: Multiple Vaccines for RSV Now Available
Pfizer/BioNTech Seek US FDA Approval for 12+ Covid Vaccine
Covid vaccine safety report – 23-02-2023
TGA provisionally approves Moderna’s new bivalent Covid vaccine
Boosters on Alert for Winter: NZ Gov Plan
FDA, EMA Accept Pfizer’s Elranatamab Filing
FDA Grants Pfizer’s RSV Vaccine Candidate Priority Review
Moderna’s COVID Booster Dose Vaccine Approved by TGA Provisionally
Victorian Heart Hospital Opens, Southern Hemisphere’s 1st
Pfizer: Positive Data from Phase 3 TALAPRO-2 Study of TALZENNA & XTANDI
Pfizer Publishes Phase 3 Data on Zavegepant for Migraine Treatment
Final days to nominate stroke hero
Ide-Cel CAR T Therapy Offers Hope for Treating Recurrent Myeloma
FDA OKs Pfizer’s Abrocitinib for Supplemental Use
New Test 1000x More Sensitive Than Conventional Tests